This programme will examine the current state of GMP.
It will focus on current key aspects, including the evolution of cGMPs since the publication of ICH Q7 in 2000 and the potential impact of the ICH Implementation Group and their development of Q&As relating to ICH Q7.
The symposium will also examine the implications of the EMA Guideline covering shared facilities and revisions to approaches to the calculation of exposure limits. What impact will the Guidelines have on your shared facilities – and what steps do you need to consider to address the challenges?
It will focus on current key aspects, including the evolution of cGMPs since the publication of ICH Q7 in 2000 and the potential impact of the ICH Implementation Group and their development of Q&As relating to ICH Q7.
The symposium will also examine the implications of the EMA Guideline covering shared facilities and revisions to approaches to the calculation of exposure limits. What impact will the Guidelines have on your shared facilities – and what steps do you need to consider to address the challenges?
